S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Stock market today: Asian stocks rise after Wall St retreats on concern economy weakening
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Stock market today: Asian stocks rise after Wall St retreats on concern economy weakening
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Stock market today: Asian stocks rise after Wall St retreats on concern economy weakening
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Stock market today: Asian stocks rise after Wall St retreats on concern economy weakening
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
NASDAQ:HSIC

Henry Schein (HSIC) Stock Forecast, Price & News

$75.26
+0.84 (+1.13%)
(As of 06/5/2023 ET)
Compare
Today's Range
$73.67
$75.53
50-Day Range
$73.43
$85.22
52-Week Range
$64.75
$89.72
Volume
813,608 shs
Average Volume
868,291 shs
Market Capitalization
$9.86 billion
P/E Ratio
21.50
Dividend Yield
N/A
Price Target
$85.67

Henry Schein MarketRank™ Forecast

Analyst Rating
Hold
2.25 Rating Score
Upside/​Downside
13.8% Upside
$85.67 Price Target
Short Interest
Healthy
2.90% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.42
Upright™ Environmental Score
News Sentiment
1.08mentions of Henry Schein in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$3.16 M Sold Last Quarter
Proj. Earnings Growth
8.17%
From $5.26 to $5.69 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.41 out of 5 stars

Medical Sector

172nd out of 986 stocks

Medical & Hospital Equipment Industry

2nd out of 3 stocks


HSIC stock logo

About Henry Schein (NASDAQ:HSIC) Stock

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

Receive HSIC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Henry Schein and its competitors with MarketBeat's FREE daily newsletter.

HSIC Stock News Headlines

Brokerages Set Henry Schein, Inc. (NASDAQ:HSIC) PT at $85.67
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
Henry Schein (NASDAQ:HSIC) Downgraded by StockNews.com
The Latest Analyst Ratings for Henry Schein
Q1 2023 Henry Schein Inc Earnings Call
Why Henry Schein Shares Are Falling Today
Henry Schein Inc. Q1 Profit Decreases, misses estimates
See More Headlines

HSIC Price History

HSIC Company Calendar

Last Earnings
5/09/2023
Today
6/05/2023
Next Earnings (Estimated)
8/01/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Medical & hospital equipment
Sub-Industry
Health Care Distributors
Sector
Medical
Current Symbol
NASDAQ:HSIC
CUSIP
80640710
Employees
22,000
Year Founded
1932

Price Target and Rating

Average Stock Price Forecast
$85.67
High Stock Price Forecast
$97.00
Low Stock Price Forecast
$69.00
Forecasted Upside/Downside
+13.8%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
8 Analysts

Profitability

Net Income
$538 million
Pretax Margin
5.15%

Debt

Sales & Book Value

Annual Sales
$12.65 billion
Cash Flow
$6.53 per share
Book Value
$30.21 per share

Miscellaneous

Free Float
129,510,000
Market Cap
$9.86 billion
Optionable
Optionable
Beta
0.83

Social Links


Key Executives

  • Stanley M. BergmanStanley M. Bergman
    Chairman & Chief Executive Officer
  • James P. BreslawskiJames P. Breslawski
    Vice Chairman & President
  • Michael Saul EttingerMichael Saul Ettinger
    Chief Operating Officer & Executive Vice President
  • Ronald N. South
    Chief Financial Officer & Senior Vice President
  • Christopher Pendergast
    Chief Technology Officer & Senior Vice President













HSIC Stock - Frequently Asked Questions

Should I buy or sell Henry Schein stock right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Henry Schein in the last twelve months. There are currently 1 sell rating, 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" HSIC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HSIC, but not buy additional shares or sell existing shares.
View HSIC analyst ratings
or view top-rated stocks.

What is Henry Schein's stock price forecast for 2023?

8 brokers have issued 1-year price objectives for Henry Schein's shares. Their HSIC share price forecasts range from $69.00 to $97.00. On average, they expect the company's stock price to reach $85.67 in the next year. This suggests a possible upside of 13.8% from the stock's current price.
View analysts price targets for HSIC
or view top-rated stocks among Wall Street analysts.

How have HSIC shares performed in 2023?

Henry Schein's stock was trading at $79.87 on January 1st, 2023. Since then, HSIC shares have decreased by 5.8% and is now trading at $75.26.
View the best growth stocks for 2023 here
.

When is Henry Schein's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 1st 2023.
View our HSIC earnings forecast
.

How were Henry Schein's earnings last quarter?

Henry Schein, Inc. (NASDAQ:HSIC) posted its earnings results on Tuesday, May, 9th. The company reported $1.21 earnings per share for the quarter, missing analysts' consensus estimates of $1.23 by $0.02. The business had revenue of $3.06 billion for the quarter, compared to analysts' expectations of $3.09 billion. Henry Schein had a trailing twelve-month return on equity of 15.41% and a net margin of 3.82%. The business's revenue was down 3.7% compared to the same quarter last year. During the same period last year, the company posted $1.30 earnings per share.
Read the conference call transcript
.

When did Henry Schein's stock split?

Shares of Henry Schein split before market open on Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly created shares were distributed to shareholders after the market closes on Thursday, September 14th 2017. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

How will Henry Schein's stock buyback program work?

Henry Schein announced that its board has approved a share buyback program on Thursday, August 18th 2022, which permits the company to buyback $400,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to purchase up to 4% of its stock through open market purchases. Stock buyback programs are usually an indication that the company's management believes its shares are undervalued.

What guidance has Henry Schein issued on next quarter's earnings?

Henry Schein issued an update on its FY 2023 earnings guidance on Tuesday, May, 9th. The company provided earnings per share (EPS) guidance of $5.18-$5.35 for the period, compared to the consensus EPS estimate of $5.33. The company issued revenue guidance of $12.77 billion-$13.03 billion, compared to the consensus revenue estimate of $12.83 billion.

What is Stanley M. Bergman's approval rating as Henry Schein's CEO?

451 employees have rated Henry Schein Chief Executive Officer Stanley M. Bergman on Glassdoor.com. Stanley M. Bergman has an approval rating of 94% among the company's employees. This puts Stanley M. Bergman in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Henry Schein own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Henry Schein investors own include Alibaba Group (BABA), Pfizer (PFE), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), NVIDIA (NVDA), QUALCOMM (QCOM), CVS Health (CVS), Micron Technology (MU) and AT&T (T).

What is Henry Schein's stock symbol?

Henry Schein trades on the NASDAQ under the ticker symbol "HSIC."

Who are Henry Schein's major shareholders?

Henry Schein's stock is owned by a variety of retail and institutional investors. Top institutional investors include Generation Investment Management LLP (9.44%), BlackRock Inc. (7.85%), Longview Partners Guernsey LTD (5.54%), State Street Corp (5.15%), Perpetual Ltd (3.25%) and American Century Companies Inc. (3.07%). Insiders that own company stock include Bradford C Connett, Deborah Derby, Gerald A Benjamin, James P Breslawski, Kurt P Kuehn, Lorelei Mcglynn, Mark E Mlotek, Michael S Ettinger, Philip A Laskawy, Scott Philip Serota, Stanley M Bergman, Steven Paladino and Walter Siegel.
View institutional ownership trends
.

How do I buy shares of Henry Schein?

Shares of HSIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Henry Schein's stock price today?

One share of HSIC stock can currently be purchased for approximately $75.26.

How much money does Henry Schein make?

Henry Schein (NASDAQ:HSIC) has a market capitalization of $9.86 billion and generates $12.65 billion in revenue each year. The company earns $538 million in net income (profit) each year or $3.50 on an earnings per share basis.

How many employees does Henry Schein have?

The company employs 22,000 workers across the globe.

Does Henry Schein have any subsidiaries?
The following companies are subsidiares of Henry Schein: ACE Surgical Supply Co. Inc., ADS Florida, AUV Veterinary Services, Accord, Alpha Scientific, Arcade Dentaire, Arseus, Arseus Dental Solutions, Arseus Lab, Becker-Parkin Dental Supply, BioHorizons Inc., Butler Schein Animal Health, C&M Vetlink, Camlog USA Inc., DNA Anthos Impianti, Dental Cremer, Dental Trey, Elite Computer Italia, Exan Enterprises Inc., HS Brand Management LLC, HS TM Holdings LLC, HSFR Inc., Handpiece Parts & Repairs Inc., Henry Schein Europe Inc., Henry Schein Global Sourcing Inc., Henry Schein Latin America Pacific Rim Inc., Henry Schein Medical Systems Inc., Henry Schein Practice Solutions Inc., InSource Inc., Jorgen Kruuse, Lincoln Dental Supply, Logiciel Julie, Maddox Practice Group, Maravet, Marrodent, Medivet, Medka, Minerva Dental Limited, Modern Laboratory Services, NLS Animal Health, Noviko, Ortho Organizers, Ortho Technology, Prism Medical Products L.L.C., Prism Medical Products LLC, Project Helium Holdings LLC, Project Spartan Holdings Corp., RxWorks, SG Healthcare Corp., Sirona Direct, SmartPak Equine LLC, Software of Excellence, Sogim Grimouille, Southern Anesthesia & Surgical, S & S Discount Inc., TDSC Inc., The Exan Group, Veterinary Instrumentation, Vetstreet, W. & J. Dunlop, eAssist Inc., and scil animal care.
Read More
How can I contact Henry Schein?

Henry Schein's mailing address is 135 DURYEA RD, MELVILLE NY, 11747. The official website for the company is www.henryschein.com. The company can be reached via phone at (631) 843-5500, via email at steven.paladino@henryschein.com, or via fax at 631-843-5541.

This page (NASDAQ:HSIC) was last updated on 6/6/2023 by MarketBeat.com Staff

My Account -